Biotechnology Stocks I Performance Guide: Gyre Therapeutics, Inc. (GYRE)
GYRE has no dividends.
Table and Chart of GYRE Performance
See what a $1,000 investment in GYRE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| GYRE Returns | |
|---|---|
| Start Date | Oct-31-2014 |
| Start Price | $47.54 |
| End Date | Oct-04-2024 |
| End Price | $13.47 |
| # Prices | 121 |
| Min Date | Apr-29-2022 |
| Min Price | $0.15 |
| Max Date | Mar-31-2015 |
| Max Price | $60.34 |
| Total Return | -71.66% |
| Annualized Return | -11.76% |
| Current Value of $1,000 Purchase | $283 |
| Number Returns | 7,260 |
| Average Return | 188.05% |
| Number Profitable Returns | 2,780 |
| Percent Profitable Returns | 38.29% |
| Number Unprofitable Returns | 4,480 |
| Percent Unprofitable Returns | 61.71% |
| Profitable to Unprofitable Returns Ratio | 0.62 |
| GYRE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | 61.510 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | 20081000 |
| PE to Growth Ratio | None |
| Price to Book | 11.28 |
| PRICE DATA | |
| 52 Week High | $None |
| 52 Week Low | $30.4 |
| Analyst Target Price | $-0.14 |
| 50-Day Moving Average | $4.8 |
| 200-Day Moving Average | $12.56 |
| FINANCIAL DATA | |
| Revenue per Share | $-1 |
| Revenue | $-1 |
| Profit Margin | 146.4% |
| Return on Equity | 10.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
GYRE Compare Returns with S&P 500
GYRE Trendline Chart
GYRE Moving Average Chart
GYRE Stock Return Map - See Patterns of Gains and Losses
GYRE Stock Returns/Purchase Dates